SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-021542
Filing Date
2023-06-16
Accepted
2023-06-16 06:10:19
Documents
83
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 1518151
2 form20-f_001.jpg GRAPHIC 5232
3 form20-f_002.jpg GRAPHIC 8970
4 ex12-1.htm EX-12.1 16868
5 ex12-2.htm EX-12.2 16672
6 ex13-1.htm EX-13.1 6540
7 ex13-2.htm EX-13.2 6271
8 ex-15.htm EX-15 165656
  Complete submission text file 0001493152-23-021542.txt   6248063

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE avcrf-20221231.xsd EX-101.SCH 56950
10 XBRL CALCULATION FILE avcrf-20221231_cal.xml EX-101.CAL 64181
11 XBRL DEFINITION FILE avcrf-20221231_def.xml EX-101.DEF 177502
12 XBRL LABEL FILE avcrf-20221231_lab.xml EX-101.LAB 371701
13 XBRL PRESENTATION FILE avcrf-20221231_pre.xml EX-101.PRE 286670
77 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 974264
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-51848 | Film No.: 231019298
SIC: 2834 Pharmaceutical Preparations